Ionis Pharmaceuticals, Inc. (IONS)
NASDAQ: IONS · Real-Time Price · USD
80.30
-1.24 (-1.52%)
Jan 9, 2026, 4:00 PM EST - Market closed
Ionis Pharmaceuticals Stock Forecast
Stock Price Forecast
The 22 analysts that cover Ionis Pharmaceuticals stock have a consensus rating of "Strong Buy" and an average price target of $83.64, which forecasts a 4.16% increase in the stock price over the next year. The lowest target is $39 and the highest is $110.
Price Target: $83.64 (+4.16%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Ionis Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 8 | 9 | 9 | 9 | 9 |
| Buy | 5 | 6 | 8 | 8 | 9 | 9 |
| Hold | 4 | 4 | 4 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 15 | 18 | 21 | 21 | 22 | 22 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Maintains $82 → $100 | Buy | Maintains | $82 → $100 | +24.53% | Jan 5, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $82 → $95 | Buy | Maintains | $82 → $95 | +18.31% | Dec 17, 2025 |
| Leerink Partners | Leerink Partners | Buy Maintains $85 → $100 | Buy | Maintains | $85 → $100 | +24.53% | Dec 15, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $86 → $97 | Strong Buy | Maintains | $86 → $97 | +20.80% | Dec 9, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $100 → $110 | Strong Buy | Maintains | $100 → $110 | +36.99% | Nov 10, 2025 |
Financial Forecast
Revenue This Year
914.68M
from 705.14M
Increased by 29.72%
Revenue Next Year
923.51M
from 914.68M
Increased by 0.97%
EPS This Year
-2.31
from -3.04
EPS Next Year
-3.12
from -2.31
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 968.8M | 1.2B | ||||
| Avg | 914.7M | 923.5M | ||||
| Low | 847.7M | 673.1M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 37.4% | 30.3% | ||||
| Avg | 29.7% | 1.0% | ||||
| Low | 20.2% | -26.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -1.94 | -1.59 | ||||
| Avg | -2.31 | -3.12 | ||||
| Low | -2.42 | -4.26 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.